ReviewFrontiers in immunology2022
PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy.
Qian Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
174 papers cite itlatest 60 shown
this paperpooled itcites it